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Abstract
Expansion of the polyglutamine (polyQ) track of the Huntingtin (HTT) protein above 36 is
associated with a sharply enhanced risk of Huntington’s disease (HD). Although there is
general agreement that HTT toxicity resides primarily in N-terminal fragments such as the
HTT exon1 protein, there is no consensus on the nature of the physical states of HTT exon1
that are induced by polyQ expansion, nor on which of these states might be responsible for
toxicity. One hypothesis is that polyQ expansion induces an alternative, toxic conformation
in the HTT exon1 monomer. Alternative hypotheses posit that the toxic species is one of
several possible aggregated states. Defining the nature of the toxic species is particularly
challenging because of facile interconversion between physical states as well as challenges
to identifying these states, especially in vivo. Here we describe the use of fluorescence cor-
relation spectroscopy (FCS) to characterize the detailed time and repeat length dependent
self-association of HTT exon1-like fragments both with chemically synthesized peptides in
vitro and with cell-produced proteins in extracts and in living cells. We find that, in vitro,
mutant HTT exon1 peptides engage in polyQ repeat length dependent dimer and tetramer
formation, followed by time dependent formation of diffusible spherical and fibrillar oligo-
mers and finally by larger, sedimentable amyloid fibrils. For expanded polyQ HTT exon1
expressed in PC12 cells, monomers are absent, with tetramers being the smallest molecu-
lar form detected, followed in the incubation time course by small, diffusible aggregates at
6–9 hours and larger, sedimentable aggregates that begin to build up at 12 hrs. In these cell
cultures, significant nuclear DNA damage appears by 6 hours, followed at later times by
caspase 3 induction, mitochondrial dysfunction, and cell death. Our data thus defines limits
on the sizes and concentrations of different physical states of HTT exon1 along the reaction
profile in the context of emerging cellular distress. The data provide some new candidates
for the toxic species and some new reservations about more well-established candidates.
Compared to other known markers of HTT toxicity, nuclear DNA damage appears to be a
relatively early pathological event.
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Introduction
Susceptibility to Huntington’s disease (HD) is tightly linked to the expansion of a polygluta-
mine (polyQ) repeat sequence in the N-terminal segment of the protein huntingtin (HTT), but
there is no consensus on how this repeat expansion endows the HTT protein with a toxic gain
of function [1–3]. Short N-terminal fragments of HTT containing the polyQ domain, and in
particular the HTT exon1 fragment, may well play a key role in the molecular mechanism of
disease [4]. The prevailing model for the effect of repeat expansion is that it alters the folding
landscape of these fragments, enriching the molecular ensemble in a conformational or assem-
bly state whose interactions with key cellular targets produce cell dysfunction and death. One
approach to experimentally addressing the challenge of expanded polyQ toxicity is to divide it
into a series of more manageable individual problems. Here, we focus on the question of how
the expansion of the polyQ sequence changes the folding / misfolding landscape of HTT exon1
fragments, and whether certain physical states are suppressed or elevated in response to repeat
expansion.
Fragments like HTT exon1 consist of three segments, each of which is intrinsically disor-
dered in the monomeric state [5] (Fig 1). Early experiments using a polyQ-specific antibody
suggested a possible repeat length dependent conformational change within monomeric polyQ
[6]. However, more recent work indicates a common compact coil state in both normal and
pathological repeat lengths of polyQ [7], and a relatively short polyQ antibody epitope [8]
whose binding strength to antibodies (and to possible cellular toxicity targets) depends on the
number of independent epitopes within the chain [9,10]. Repeat length dependent formation
of dimers or tetramers is another possible mechanism for repeat length dependence of disease,
but there is no consensus on the multimeric state of HTT proteins. Purified, full-length HTT
expressed in insect [11] or mammalian [12] cells has been shown by gels and/or by analytical
ultracentrifugation (AUC) to contain appreciable amounts of dimer and higher multimers in
addition to monomeric material. In contrast, full length HTT isolated from HD brain material,
HD mouse model brains, or HD mouse model primary neurons has been shown to be mono-
meric [13]. Likewise, the low molecular weight form of purified, recombinantly expressed HTT
exon1 has also been shown to be monomeric by AUC [14] and by size exclusion chromatogra-
phy (SEC) coupled with multi-angle light scattering [10]. In contrast, however, AUC showed
that fragments consisting of the N-terminal HTTNT peptide (Fig 1) alone or followed by a Q10
sequence form distributions of monomer, tetramers, octamers and higher oligomers [15].
Recently, ion mobility mass spectrometry (MS) analysis revealed that in the gas phase the iso-
lated HTTNT fragment populates species ranging frommonomer to tetramer [16]. Similar mul-
timers of HTT exon1 might be the toxic species in a toxic gain-of-function mechanism, or
might serve as vehicles by which mutant HTT fragments incapacitate WT fragments in a domi-
nant negative disease mechanism [17]. Oligomers lacking β-structure have also been impli-
cated as the phase within which polyQ amyloid fibril initiation takes place [5,15,18,19], one
model for which is illustrated in Fig 1A.
Formation of amyloid-like aggregates is a common feature of physiological conditions
involving Gln-rich proteins, from HD [20] to other expanded polyQ repeat diseases [21] to
yeast prions [22]. Observations of large, polyQ-positive inclusions in neuronal nuclei in HD
autopsy material [23] and animal models [24] implicated a role for protein aggregation in the
HD disease process. This idea received additional support from reports of a repeat length
dependence to aggregation in vivo [25] and in vitro [26,27] that recapitulates the repeat length
dependence of disease risk and age-of-onset [3]. There are mixed results, however, on whether
inclusions themselves might be the toxic species [28,29]. In any case, substantially smaller
aggregated forms of HTT exon1 have been observed by electron microscopy (EM) and atomic
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force microscopy (AFM) when HTT exon1 is incubated in vitro [30], and have also been seen
in fixed cells, cell extracts, and brain homogenates using native gels [31], SEC [32], glycerol gra-
dient centrifugation [33], AFM [34], EM [34], and super-resolution fluorescence microscopy
[35]. Most of these methods do not lend themselves to quantitation of aggregate size and con-
centration, however, and there have been only limited studies of the temporal linkage between
the appearance of these smaller aggregates and the onset of pathology [31–34]. In one example,
Leitman et al. identified a population of “soluble” oligomers associated with a degree of ER
stress [33] that has been previously implicated in HD toxicity [36].
There are few tools available to study protein self-association at low physiological concen-
trations in living or fixed intact cells. Fluorescence microscopy has been used to visualize inclu-
sions of fluorescently tagged proteins such as HTT exon1 in living cells [28]. These inclusions
are multiple microns in diameter and may contain up to a billion protein molecules [37].
Smaller aggregates are not observable with this technique, but super-resolution fluorescence
microscopy on fixed cells reveals clusters of amyloid fibrils in the range of a micron in length
[38] that may contain up to 100,000 HTT molecules [37], and further refinements have led to
visualization of smaller, single fibrils in the 1 μm length range [35]. Number and brightness
analysis assessing spatial fluctuations of fluorescence intensity in confocal images revealed a
mixture of monomers and small oligomers in the 5–15 range in early growth time points in
mammalian cells expressing expanded polyQ HTT exon1 [39].
Fluorescence correlation spectroscopy (FCS) assessing temporal fluctuations in fluorescence
intensity under conditions of free diffusion in solution [40] is a powerful and highly accurate
Fig 1. Structures and assemblymechanism of HTT exon1 polypeptides. A. Previously proposed mechanism of amyloid nucleation (HTTNT,
green; polyQ, orange; PRD, black). B. Sequence of HTT exon1. C. Sequences of peptides studied. C* = Cys residue modified with Alexa Fluor
555 (see Materials and Methods).
doi:10.1371/journal.pone.0155747.g001
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technique for characterizing molecular sizes of fluorescently tagged molecules at relatively low
concentrations in simple buffers and cell extracts [41] as well as in living cells [42]. However,
FCS has been used only rarely in the study of protein aggregates and aggregation [43].
In the work described here we set out primarily to identify the molecular cast of characters
populated by normal and polyQ repeat expanded HTT exon1 in aqueous systems. We use FCS
to characterize and quantify the self-association states of HTT exon1 peptides both with chemi-
cally synthesized peptides in vitro and with expressed peptides in mammalian cell culture, and
track how oligomerization states change with repeat length and incubation/growth time. We
also characterize several markers of cell pathology over the same time frame. This work pro-
vides new insights into HTT exon1 self-association states and how their stabilities are influ-
enced by polyQ repeat length. For expanded polyQ forms of HTT exon1, the work reveals the
absence of detectible monomers but the presence of several small, self-associated forms, includ-
ing dimers, tetramers and diffusible oligomers ranging from globular to fibrillary, that appear
in the same time frame as the first identifiable cell pathology.
Results
In FCS, a confocal microscope with laser optics that create a femptoliter focal volume is modi-
fied to allow time-dependent fluorescence fluctuations to be quantified with great sensitivity,
accuracy and temporal resolution [40]. Using an autocorrelator, these fluctuations can be com-
putationally modelled to derive the diffusion times and numbers of fluorescently labelled parti-
cles traversing the focal volume. These values can in turn be used to calculate molecular sizes
and concentrations [40,41]. Although FCS is most accurate when characterizing systems at
equilibrium [41], in principle it can be used to characterize aggregating systems, so long as
aggregation times are slow in comparison to fluorescence data collection times under the con-
ditions of measurement [40]. In spite of the complexity and relatively high viscosity of the
intracellular environment, interpretable FCS data can even be obtained from measurements in
living cells [42,44].
HTT exon1 analogs in simple buffer: repeat-length and concentration
dependent multimerization
In order to map out the basic physical behavior of the HTT exon1 peptide system, we first
investigated chemically synthesized HTT exon1 analogs containing the relatively small Alexa
fluor-555 fluorescent dye covalently attached to a Cys residue placed near the C-termini of the
peptides (Fig 1C). These analogs contained either a Q23 or a Q37 repeat, and a truncated pro-
line-rich domain (PRD) consisting of a P10 sequence (Fig 1C). Importantly, such P10 analogs
have been shown to behave similarly to full-length HTT exon1 in their aggregation properties,
including details of the aggregation mechanism [18,37]. These peptides were disaggregated
(Materials and Methods), suspended in PBS at 30 nM, and examined by FCS after a 10 min
equilibration period at RT. The raw time-dependent fluorescence data (Fig 2A) show that both
peptides exhibit fluorescence fluctuations within a fairly narrow intensity range, and the auto-
correlation functions (Fig 2B) of these data are consistent with a single component. However,
while the HTTNTQ23P10CK2 molecule (Fig 2B, red curve) was found to exist as a monodis-
perse solution of monomers, the expanded polyQ analog HTTNTQ37P10CK2 (Fig 2B, black
curve) exists as a monodisperse solution of tetramers, with no monomers evident (Table 1).
A particle’s diffusion time (τd) in a particular buffer is influenced not only by mass but also
by molecular shape. Although it seems highly unlikely that a conformational change within a
Q37 HTT exon1-like monomer could account for a 400% increase in predicted mass, it was
important to consider whether a repeat length dependent conformational change might be an
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alternative explanation for the substantially increased diffusion times observed for
HTTNTQ37P10CK2. After analysis, however, all the considerations below support multimeriza-
tion and not shape changes being responsible for these increases. First, monomer-tetramer
equilibria have already been described for HTTNT-containing peptides using analytical ultra-
centrifugation [15] and ion mobility MS [16]. Second, analysis shows that the diffusion times
of both the Q23 and the Q37 peptides increase sigmoidally as peptide concentration increases
(Fig 2C). This behavior is not consistent with a conformational change (which should be con-
centration independent), but is completely consistent with a simple mass action concentration
effect on a monomer-dimer-tetramer self-association equilibrium. Third, estimates of the aver-
age molecular size in these samples by considering the statistical distribution of fluorescence
Fig 2. Self-assembly in PBS of chemically synthesized HTT exon1 analogs. A. Raw FCS time-dependent fluorescence fluctuations of
HTTNTQ23P10C*K2 (red) and HTT
NTQ37P10C*K2 (black). B. Autocorrelation functions for the 10 mins FCS data shown in A, with the data
points as filled squares and solid lines representing the fits (see Materials and Methods) and the same color scheme as A. Lines below the
graph show the residuals between the data points and the fit curve. C. Concentration dependence of molecular size estimated from diffusion
times for HTTNTQ37P10C*K2 (■) and HTT
NTQ23P10C*K2 (●). D. EM detail of different time points from the PBS incubation of a mixture of
2.0 μMHTTNTQ37P10K2. (More EM data is shown in S1 Fig.)
doi:10.1371/journal.pone.0155747.g002
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intensities (“brightness analysis”; [40,45]) shows sizes consistent with FCS results. Thus, we
used two different methods to analyze data from a HTTNTQ23P10CK2 solution in the concen-
tration range where the peptide was found by FCS diffusion times to be dimeric (Fig 2C). Both
of these methods (see Methods section), which—importantly—are shape independent, return a
dimer-associated value for the number of Alexa fluorophores per particle: the photon counting
histogram (PCH) method gave a value of 2.33, and the FCS autocorrelation curve method a
value of 2.21. Fourth, elimination of the HTTNT segment leads to loss of multimerization, as
expected if dimer and tetramer formation are primarily driven by the HTTNT segment
[15,16,18,37]. Thus, a 150 nM PBS solution of Q37 peptide containing the P10 segment but lack-
ing the HTTNT segment (Fig 1C) yields diffusion times associated with monomer as the single
component, instead of the tetramer observed for 150 nMHTTNTQ37P10CK2 (Table 1). The
above data strongly implicate a regular multimerization process as being responsible for
observed diffusion times.
HTT exon1 analogs in simple buffer: repeat-length and time-dependent
aggregation
Further incubation of the Q23 molecule for 90 mins before FCS data were collected produced
no change in the data (Fig 2A). However, 90 mins pre-incubation of the Q37 molecule gener-
ated a much more complex pattern featuring a series of spikes of high fluorescence intensity in
addition to the narrow intensity fluctuations seen before (Fig 2A). When these data are ana-
lyzed by a two-component fit, they give a good correlation with a model consisting of tetramers
plus a collection of larger, diffusible oligomers averaging 84 molecules of HTT exon1 per
Table 1. Summary of FCS data showingmolecular sizes under various conditions.
Sample time and/or conc.a τD1, μsec
b τD2, μsec
b Size1c Size2c
HTTNTQ23P10C*K2 30 nM, 10 mins 92 - 0.98 -
HTTNTQ37P10C*K2 30 nM, 10 mins 160 - 3.8 -
HTTNTQ37P10C*K2 30 nM, 90 mins 167 447 4.1 84
HTTNTQ30P10C*K2 150 nM, 10 mins 146 3.7
K2Q30P10C*K2 150 nM, 10 mins 90 0.98
K2Q30P10C*K2 150 nM, 40 mins 91 0.98
K2Q30P10C*K2 150 nM, 90 mins 97 1.0
GFP extr. (extract) transient transfect. 150 - 1.0 -
HTT exon1-Q25-EGFP extr. 24 hrs 181 - 1.1 -
HTT exon1-Q97-EGFP extr. 0 hrs 270 - 3.4 -
HTT exon1-Q97-EGFP extr. 3 hrs 275 - 3.6 -
HTT exon1-Q97-EGFP extr. 6 hrs 281 503 3.9 21
HTT exon1-Q97-EGFP extr. 9 hrs 285 544 4.0 27
HTT exon1-Q97-EGFP extr. 12 hrs 295 1856 4.5 1096
HTT exon1-Q97-EGFP extr. 16 hrs 278 2138 3.7 1675
HTT exon1-Q97-EGFP extr. 24 hrs 266 2550 3.3 2843
GFP in cell transient transfect. 1450 - 1.0 -
HTT exon1-Q25-EGFP in cell 6 hrs 1403 - 0.95 -
HTT exon1-Q97-EGFP in cell 6 hrs 2111 - 3.4 -
aCells: post-induction growth times; peptides: concentrations and pre-measurement incubation time.
bDiffusion times of species #1 and (if any) species #2.
cNumber of HTT exon1-like peptides per particle in species #1 and #2.
doi:10.1371/journal.pone.0155747.t001
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aggregate (Table 1). Interestingly, incubation of a substantially higher concentration of
K2Q37P10CK2 lacking HTT
NT does not lead to formation of any detectable diffusible oligo-
mers even after 90 mins (Table 1), supporting earlier studies suggesting that HTTNT is required
for formation of oligomers [15,18].
To better understand the structures of these oligomers, we monitored the incubation time
dependence of 2 μM solutions of HTTNTQ37P10K2 by parallel FCS and EM analysis. Two μM is
the minimal concentration we have found that allows collection of meaningful EM data, and
also is in the concentration range for newly synthesized HTT exon1 in our cell model (see
below). By EM (Fig 2, Table 2, S1 Fig), we observed rapid formation of spherical oligomers of
fairly uniform, relatively small size, ranging from an average of ~100 HTT exon1 molecules at
15 mins to an average of ~250 molecules at 30 mins (Table 2). At 60 mins EM images show a
highly homogeneous array of filamentous aggregates, similar to what are generally referred to
as protofibrils in other amyloid systems [46], which also contain on average ~ 700 molecules of
HTT exon1 each (Table 2). At 100 mins we observed by EM a highly heterogeneous distribu-
tion of aggregates including both very large super-assemblies of filaments and very short amy-
loid-like fibrils; these smaller fibrils are estimated to average ~ 500 molecules of HTT exon1
per aggregate (Table 2). After 2 days of incubation we observed arrays of amyloid fibrils of uni-
form diameters but variable lengths. These correspond to ~ 3,000 +/- 500 molecules of HTT
exon1 per fibril (Table 2). Previously, similar spherical oligomers, protofibrils and short fibrils
have been reported for HTT fragments aggregating in vitro and in vivo [18,30,34,37]. FCS mea-
surements showed reasonable agreement with the rough estimates of particle size based on
analysis of EM images (Table 2). At all reaction times examined, the data were well described
by a two-component fit in which one component is a tetramer and the other is a collection of
larger oligomeric structures whose sizes increase as reaction time increases. At 20–30 mins the
larger component has an average size of 250–350 molecules per particle; at 60 mins, ~300 mol-
ecules per particle; and at 90 mins, ~850 molecules per particle. By 120 mins diffusion times
give a value of about 2,600 molecules per particle, similar to the small amyloid fibrils character-
ized by EM after 2 days. At later times (including 2 days) reaction time points give FCS data
that cannot be fit to a model, as normally occurs with larger, heterodisperse particles.
Table 2. Aggregation time course of HTTNTQ37P10C*K2 by EM and FCS.
Electron Microscopya FCS
Time, mins # peptidesb,e size1, # peptidesb size2, #peptidesb
5 NDc 4.3 -
15–20 112 ± 26 3.7 232
30 257 ± 78 3.9 369
40 NDc 3.6 321
60 704 ± 63 4.1 299
90–100 513 ± 86 3.5 854d
120 NDc 3.3 2,626d
2,880 2,964 ± 450 NDc,d NDc,d
aIn EM grids exhibiting both small and very large aggregates, only the small aggregates were chosen for this calculation (since the large aggregates would
be invisible in FCS).
bCalculated number of peptide molecules per particle.
cND = not determined.
dThese samples gave very heterogeneous data sets, many of which were not analyzable by FCS
eAll calculated sizes are averages of 10–15 aggregates.
doi:10.1371/journal.pone.0155747.t002
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HTT exon1 in cells and cell extracts: repeat-length dependent
multimerization and repeat length and time-dependent aggregation
We then carried out similar FCS analysis of clarified lysates of mammalian cells stably trans-
fected and induced to produce full length HTT exon1 (Fig 1) fused at the C-terminus to EGFP
and containing polyQ repeats of either 25 or 97 Gln [47]. In previous studies of this PC12 cell
model, the Q25 version was shown to produce a diffuse EGFP fluorescence uniformly through-
out the cytoplasm regardless of growth time, while the Q97 version exhibited diffuse fluores-
cence at early growth times but large inclusions at 24 hrs [47]. We observed exactly the same
fluorescence microscopy behavior in our own work with these cells (Fig 3A and 3B).
Probing further, we found that clarified extracts of Q25 cells grown for 3 hrs with 1 μM of
the ponesterone inducer exhibit a tight range of fluorescence fluctuations (Fig 4A) giving an
autocorrelation function (Fig 4B, black curve) that is best fit to a single component monomeric
species (Table 1). Similar data are obtained for extracts prepared from cells grown for 6 and 24
hrs (Fig 4A), except that the FCS-evaluated monomer concentrations increase at longer growth
times (see below). In contrast, the Q97 version gives data on clarified extracts of 3 hrs post-
induction cells (Fig 4A) that are most consistent with a monodisperse solution of tetramers
(Fig 4C, red curve; Table 1). In contrast, extracts of cells grown for 6 hrs exhibit a baseline of
fluorescence attributed to tetramers, plus occasional spikes of high fluorescence intensity
(Fig 4A) consistent with diffusible oligomers in the size range of 20-mers (Fig 4C, Table 1). By
24 hrs, tetramers persist, but there are also many additional fluorescence spikes (Fig 4A), the
average size of which has grown to a range of ~3,000 HTT exon1 molecules per diffusible
aggregate (Fig 4C, Table 1).
We also analyzed the self-association states of HTT exon1 molecules by conducting FCS in
living cells. We used the confocal microscope capability of the FCS instrument to locate areas
Fig 3. Characteristics of the PC12model. A. Confocal microscopy of the Q25 and Q97 versions of HTT
exon1 after 6 and 24 hrs growth in the presence of 1 μM ponesterone. Blue = Hoechst dye stained nucleus;
green = EGFP. B. Number of cells containing inclusions at different growth times determined by fluorescence
microscopy. C. Percent cell death at different growth times as determined by the amount of the intracellular
enzyme lactate dehydrogenase released into the medium, an indication of the loss of outer cell membrane
integrity.
doi:10.1371/journal.pone.0155747.g003
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Fig 4. Self-assembly of full length HTT exon1-EGFP fusions in PC12 living cells and cell extracts. A.
Raw FCS data from clarified native lysates of PC12 cells after different growth times. B. Autocorrelation
functions with residuals of 24 hrs clarified native lysates of cells producing GFP alone (green) or HTT
exon1-Q25-EGFP (black). C. Autocorrelation functions with residuals of native lysate supernatants of PC12
cells producing HTT exon1-Q97-EGFP at different growth times (color code as in part A). D, E.
Autocorrelation functions with residuals of data collected from the cytoplasm of living PC12 cells producing
either HTT exon1-Q25-EGFP (D) or HTT exon1-Q97-EGFP (E).
doi:10.1371/journal.pone.0155747.g004
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of the cell cytoplasm exhibiting diffuse green fluorescence, and then collected time-dependent
fluorescence fluctuation data at these sites. We found that the EGFP fluorescence in the cyto-
plasm of HTT exon1-Q25 cells after 6 hrs exhibits an autocorrelation function consistent with a
monodisperse solution of monomers (Fig 4D, Table 1), while in the HTT exon1-Q97 cells the
fluorescence fluctuations are consistent with a monodisperse solution of tetramers (Fig 4E,
Table 1). (We note that the diffusion time of GFP alone is found to be somewhat larger than
that of the slightly larger EGFP-HTT exon1 fusion (Table 1); this significant but small pertur-
bation, which must be due to an effect of the intact cellular environment on GFP or HTT
exon1 since it is not observed in our in vitromeasurements of lysates of the same cells, does not
affect the main findings.)
Thus, in broad measure, our analysis of HTT exon1 producing cells gives data in total agree-
ment with the data on HTT exon1-like peptides in vitro. One caveat is that it is formally possi-
ble that the fluorescent particles observed in HTT exon1-Q97 cells and cell extracts might be
complexes of HTT exon1 with other cellular proteins, rather than multimers of HTT exon1.
We think this is unlikely, however, since we observe exactly the same polyQ repeat length
dependent self-association trends with chemically synthesized peptides in simple buffer as we
do in cells producing HTT exon1 (Table 1). It also seems unlikely that any of the normal inter-
action partners of HTT exon1 would be available in sufficient amounts to saturate formation
of these hypothetical complexes at the elevated concentrations of HTT exon1 (see below)
resulting from the ponesterone induction system. We did not observe any fluorescent spikes in
the intracellular measurements that are analogous to those seen in extracts of the same cells.
This is not surprising, however, since small aggregates are expected to diffuse so slowly in the
highly viscous cytoplasm that their diffusion times cannot be assessed by FCS. It is also possible
that such aggregates would not freely diffuse at all, by virtue of their interactions with cellular
structures, such as those tasked with eradicating protein aggregates [48].
HTT exon1 concentrations and molecular flux in growing cells
Autocorrelation functions also yield information on the number of particles in the focal vol-
ume [40,41], and from this information we can obtain estimates of the cellular concentrations
of different species (Materials and Methods). We took advantage of this to construct a detailed
time course of the cellular production of various HTT exon1 species (Fig 5). To avoid confu-
sion caused by changing molecular weights of different multimers, we plot the results in Fig 5
on a mass/volume basis rather than a moles/volume basis. We found that the cellular content
of HTT exon1-Q25 monomers rises to about 0.18 pg/cell (approximately 18 μM) after 24 hrs
growth post induction, while no tetramers or diffusible aggregates are detected at any time (Fig
5A). In contrast, for HTT exon1-Q97, no monomers are detected at any time (Fig 5B). Instead,
tetramers exist from the earliest measurement time and exhibit a biphasic response to growth
time, growing to a maximum of ~ 0.08 pg/cell (equivalent to a cellular concentration of about
8 μM of HTT exon1 molecules incorporated into tetramers) at 12 hrs, and then decaying to a
value of ~ 0.05 pg/cell (or about 5 μM of total HTT exon1 molecules) at 24 hrs (Fig 5B). Larger,
diffusible aggregates emerge after 6 hrs of growth and continue to rise to a final value of 0.4 pg/
cell at 24 hrs (Fig 5B). It is not possible to detect larger aggregates, such as inclusions, by FCS,
since these do not freely diffuse even in lysates. Therefore, to get a complete picture of the parti-
tioning and flux of cellular HTT exon1-Q97, we used Western blot analysis (Methods) to deter-
mine the amounts of HTT exon1 found in the pellets of the clarified cell lysates, a pool
expected to contain the remaining aggregated HTT exon1 material consisting of larger amyloid
fibrils and inclusions. We found that while such sedimentable material represents a very small
amount of HTT exon1 in the first 9 hrs of growth, levels of this class of HTT exon1-Q97
Tetramers and Aggregates of Mutant HTT Exon1
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Fig 5. Time courses of PC12 cell responses to HTT exon1 expression. A, B. Cell levels of monomer, tetramer, diffusible aggregates and
inclusions in cells producing HTT exon1-Q25-EGFP (A) or HTT exon1-Q97-EGFP (B) analyzed at different times after onset of growth with
inducer. In A, FCSmeasurements yielding information on monomers, dimers/tetramers, and diffusible oligomers were made 12, 16 and 24
hrs. In B, except for the lack of a measurement for inclusions at 3 hrs, absence of a value for a species indicates a measurement yielding a
value of zero. C, D, E. Growth time dependent effects of expression of HTT exon1 with a Q25 or Q97 repeat on nuclear DNA damage (C),
caspase-3 activation (D) and cell mitochondrial respiration (E). OCR = oxygen consumption rate.
doi:10.1371/journal.pone.0155747.g005
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material rise dramatically at 12 hrs and continue to rise through 24 hrs (Fig 5B) to a nominal
concentration of over 100 μM.
Time dependent development of cell dysfunction and death
As previously reported for this PC12 cell model [28,47], cells making HTT exon1 with either a
Q25 or Q97 polyQ repeat undergo growth time dependent cell death about equally over the first
24 hrs, after which continued cell death is more pronounced for the HTT exon1-Q97 cells (Fig
3C). Although our primary interest in this work is to use the cell model to study repeat length
dependent self-association of HTT exon1, we took advantage of the HTT exon1-dependent cell
death phenotype to study the timing of appearance of cell dysfunction and death as it compares
to the timing of aggregation phenomena. We analyzed time dependent development of nuclear
DNA damage [49,50], caspase 3 activation [51], and deficiencies in mitochondrial respiration
[52]. In a particularly striking result, we observed almost immediate nuclear DNA damage in
the cells expressing HTT exon1-Q97, with the value rising to significance by 6 hrs and continu-
ing to grow over the first 24 hrs post-induction (Fig 5C). In contrast, we found no evidence for
nuclear DNA damage over this 24 hrs period in the HTT exon1-Q25 cells (Fig 5C). Likewise,
we observed caspase 3 activation to increase slowly in the HTT exon1-Q97 cells (but not Q25
cells), reaching significance at 24 hrs (Fig 5D). Finally, we recorded oxygen consumption rates
in living cells over a 24 hr period post-induction, normalizing the mitochondrial viability data
to the number of living cells at each time point (Materials and Methods). We observed a
decline in oxygen consumption rate (OCR) at 24 hrs in cells expressing HTT exon1-Q25, but
this did not reach statistical significance (Fig 5E). Cell respiration declined steadily in the Q97
cell culture, finally reaching significance at 24 hrs (Fig 5E). To investigate whether this decay in
respiratory efficiency was due to a change in status of the mitochondria or to a change in the
metabolic pool, we permeabilized HTT exon1-Q97 cells at 24 hrs, supplied a buffer complete
with required substrates, and monitored respiration (S1 File). The results (S2 Fig) continue to
show a HTT exon1-expression dependent decay in respiration, suggesting that the data in Fig
5F owe to a reduction in fully capable mitochondria. Thus, several indicators of cell stress
develop over the first 24 hrs after expanded polyQ HTT exon1 expression is initiated and
unique self-associated forms begin to accumulate.
Discussion
We describe here robust FCS data showing several molecular states of expanded polyQ repeat
HTT exon1 that are not formed by normal repeat length versions. Short polyQ versions tend to
exist in the monomeric state, forming dimers at higher concentrations, but resist forming
higher aggregates. Expanded polyQ versions populate a dimer to tetramer equilibrium, with no
evidence for the existence of a monomeric form even at concentrations as low as 300 pM (Fig
2C). One immediate consequence of our results is the need to refine our model for HTT exon1
self-association (Fig 1) to include the presence of dimeric forms which were not observed in
previous AUC experiments on simpler HTTNT constructs [15]. The general trends in self-asso-
ciation observed here are seen with chemically synthesized peptides in PBS as well as with
recombinantly expressed peptides in cell extracts and living cells, and are also very similar
whether the FCS probe is a small molecule or a fluorescent protein.
Previously we noted that both the formation of non-β oligomers from monomer and the
nucleation of amyloid fibril formation from within these oligomers appear to independently
exhibit polyQ repeat length dependence [15,18]. Our new data demonstrate that this repeat
length dependence extends to the earliest observed self-association events. Thus,
HTTNTQ23P10CK2 populates dimers at 40 nM up to nearly 1 μM, while HTT
NTQ37P10CK2
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populates dimers in the range of 300 pM up to 3 nM (Fig 2C). A limiting value for the magni-
tude of this stabilization effect can be estimated from the curves in Fig 2C that suggest that the
midpoints of the monomer to dimer concentration dependent curves for these two peptides
must be separated by at least 100-fold. This sizable stabilizing effect is attributable to a differ-
ence in only 14 Gln residues. We can understand this effect in the context of a leading role for
HTTNT in mediating homotypic multimer formation, as suggested previously [15,16,18,53]
and demonstrated here by the loss of dimer formation, even at relatively high concentrations,
when HTTNT is removed from an HTT exon1-like peptide (Table 1, Q30 series). Thus, while
computationally predicted [54] homotypic polyQ interactions appear to be too weak to pro-
duce multimers of an HTT exon1 analog lacking the HTTNT domain (Table 1), they appear to
be sufficiently strong to enhance self-association mediated by HTTNT-HTTNT interactions.
It is not immediately obvious why FCS should reveal an HTTNT-mediated multimerization
that is sometimes not detected by other methods such as AUC [14] and SEC [10]. Although
SEC is normally considered to be a robust measurement, it nonetheless involves shear forces
and matrix surface chemistries that could potentially introduce artefacts. We note that while
some HTTNT-containing peptides behave as multimers by AUC, they migrate as monomers in
SEC [15]. In addition, the chemical state of the HTTNT segment may play an appreciable role
in multimer stability, as recently suggested by ion-mobility mass spectrometry analysis [16]. In
this context it may be relevant that most [9,14,26,30,55], but not all [56], cleavable fusion pro-
tein systems for recombinant expression of HTT exon1 generate N-termini that are modified
from the gene-encoded Met-Ala-Thr start used in our chemically synthesized and directly
expressed constructs. It appears that α-helical multimeric forms of intrinsically disordered pro-
teins are generally relatively fragile. For example, observation of helical tetramer formation by
α-synuclein [57] depends on the chemical state of the N-terminus, on isolation conditions, and
on the method of analysis [58].
Expanded polyQ versions also exhibit time dependent formation of several types of higher
aggregates. In vitro with 2 μMHTTNTQ37P10K2, we observed formation within 15–30 mins of
spherical oligomers containing 50–100 molecules of HTT exon1, then protofibrils and small,
diffusible fibrils containing hundreds of molecules of HTT exon1 at about 60 mins, then short,
diffusible amyloid fibrils in the range of 3,000 molecules of HTT exon1 by 120 mins (Fig 2D,
Table 2). Importantly, diffusible HTT exon1 particles in this same 2,000–3,000 size range begin
to accumulate in PC12 cells in the 12–24 hrs range (Table 1); the similarly of their FCS-deter-
mined sizes suggests that these cell-produced aggregates are diffusible amyloid fibrils similar to
those observed during in vitro self-association. We expect that the somewhat smaller protofi-
brillar structures identified in the in vitro experiments (Fig 2D; S1 Fig) are also transiently
formed in the cells; in other amyloid systems, such protofibrils exhibit significant β-structure
[59]. Overall, our data show that formation of initial diffusible aggregates is very efficient, tak-
ing place over only a few minutes in vitro (Fig 2; Table 2) and a few hours in cells (Table 1).
The very fast time course of diffusible aggregate formation even at low concentrations in vitro
(Fig 2; Table 1) illustrates the severe challenges facing investigators who aim to investigate the
in vitro physical and biological properties of low MW forms of HTT exon1-like peptides.
The last assembly state to form in the cell environment is the collection of very large aggre-
gates, including isolated clusters of long amyloid fibrils as well as inclusions, that pellet in a
low-speed centrifugation and are only observable by their presence in cell lysis pellets or by
fluorescence [28] or super-resolution fluorescence [38] microscopy of fixed cells. According to
our combined FCS and Western blot data, formation of aggregates clearly suppresses protein
turnover and provides a huge net enhancement of total accumulated HTT exon1 levels in the
cell, so that while the total concentration of HTT exon1-Q25 in the cell at 24 hrs is about 2 μM
(Fig 5A), the total nominal cellular concentration of the HTT exon1-Q97 peptide in all physical
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forms at 24 hrs (Fig 5B) is about 150 μM! Our results are also consistent with previous reports
[32,39] showing that concentrations of low MW forms of expanded polyQ HTT exon1 exhibit
a biphasic response to growth time due to the late development of large amyloid aggregates act-
ing as thermodynamic sinks that deplete low MW species as they are synthesized. Thus, tetra-
mers of HTT exon1-Q97 reach a maximal cellular concentration at 12 hrs, then—in spite of
continued protein production at the ribosome—begin to decline as diffusible aggregates and
inclusions build up at later time points (Fig 5B).
The sensitivity of FCS reveals the formation of diffusible aggregates within 20 mins for a
2 μM PBS solution of HTTNTQ37P10K2 (Table 2) and within 90 mins for a 30 nM solution
(Table 1). In contrast, when the substantially longer Q97 form of HTT exon1 is expressed at
low μM levels in the cell, it requires 6–9 hrs before very small diffusible aggregates begin to be
observed (Table 1). There are a number of possible explanations for why aggregation is dramat-
ically slowed in the cell, in spite of conditions in the cell experiments (much longer polyQ
repeat, micromolar concentrations, and molecular crowding) that would normally be consid-
ered to favor aggregation. For example, some cellular post-translational modifications within
the critical HTTNT segment have been shown or postulated to directly slow aggregation
[3,60,61]. In addition, the intrinsically disordered HTTNT segment is predicted to be a molecu-
lar recognition feature (MoRF) [62] capable of coupled folding and binding to other proteins
[5,18], and it is clear that the aggregation enhancing effects of HTTNT are largely neutralized
when it is bound to other proteins such as some molecular chaperones [53,63]. Thus, while
HTT exon1 aggregation in cell models appears to be quite robust, it nonetheless is actually con-
siderably suppressed compared with aggregation rates observed in simple buffer systems.
Whatever the detailed mechanisms of suppression, it is possible that modest variations in the
efficiency of these mechanisms might help explain variable susceptibilities to particular polyQ
repeat lengths by neuronal cell types and by HD patients [64].
Our linked EM and FCS data suggest that very small amyloid fibrils and protofibrils with
lengths in the range of 50–100 nm are part of a general class of diffusible (often referred to as
“soluble”) aggregates forming very early in expanded polyQ HTT exon1-producing cells,
where they constitute a bridge in the timeline between spherical, non-β oligomers and large
amyloid fibrils and inclusions. Such a result contrasts with recent super-resolution fluores-
cence microscopy studies which showed that recognizable amyloid fibrils, with lengths up to
1.5 μm, only begin to form in HTT exon1 producing cells after the appearance of inclusions
[35]. However, the resolution of super-resolution methods may be insufficient to distinguish
between fibrils and spherical oligomers in particles in the sub-μm size range; in contrast, we
observe fibrils and protofibrils in the EM with lengths in the 50–100 nm range (Fig 2D).
Alternatively, our inference, based on these in vitro EM studies, that diffusible particles con-
taining 2,000–3,000 molecules found in cell extracts are in fact fibrillary versions of HTT
exon1 may be mistaken. Resolving this issue will be important, since it may help us narrow
or expand the range of physical states of HTT exon1 that exist during the earliest stages of
the cytotoxic response. Diffusible amyloid fibrils are an exciting addition to the list of poten-
tially cytotoxic forms of aggregated HTT fragments, since they would be capable of recruit-
ing other cellular polyQ proteins through amyloid elongation in the cell [65], a process
previously suggested as a possible source of cytotoxicity [27,66].
Although our focus has been on cellular self-assembly of HTT exon1, time-dependent cell
dysfunction (Fig 5C–5E) and cell death (Fig 3C) measurements under the same growth con-
ditions provide and interesting context for the aggregation data. Our measurements of the
temporal appearance of various types of cell abnormalities provide confirmation in the PC12
model that mitochondrial dysfunction [52,67] and caspase activation [51] are associated with
expanded polyQ HTT exon1 cytotoxicity. Statistically significant levels of abnormalities
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begin to appear at 24 hrs post-induction, long after all the various self-associated forms of
HTT exon1-Q97 described here have made an appearance. Thus, by these measures, any one
of these species shown to develop over this time frame in expanded polyQ HTT exon1 cells
but not in WT HTT exon1 cells might be responsible for triggering toxic events. However, we
also find strong evidence for the time-dependent, early development of nuclear DNA damage
in the expanded polyQ HTT exon1 cells, with statistically significant levels of DNA damage
already begin to appear by 6 hrs. At this time monomers are undetectable and the steep devel-
opment of large fibrils and inclusions has not yet begun (Fig 5B). Instead, the HTT
exon1-Q97 protein is distributed between tetramers and diffusible aggregates that likely con-
sist of both non-β oligomers and small protofibrils and fibrils (Fig 5B). If the striking DNA
damage can be considered to an early aspect of expanded polyQ toxicity, from which later-
developing cellular dysfunctions develop, the data suggest that toxicity might be triggered by
HTT exon1 tetramers, non-β oligomers, and/or small amyloid fibrils. The lack of precision in
this conclusion illustrates the difficulties in assigning toxicity to a specific form of HTT
exon1, since the on-going aggregation process, fueled by new production of the peptide at the
ribosome and quickly transiting through multiple intermediates, populates a number of
forms even at the earliest stages. In addition, it should be pointed out that since we don’t
know the steady state concentration of low MW forms of HTT exon1 in neurons, nor do we
know the midpoint concentration for the monomer-dimer equilibrium for expanded polyQ
HTT exon1 (see Fig 2C), it remains possible that monomers of expanded polyQ HTT exon1
might be at least partially populated at normal cellular concentrations. Future studies investi-
gating both of these open issues are potentially critically important to the understanding of
HD disease mechanisms.
Materials and Methods
Materials and General Methods
Synthetic peptides were obtained as crude products from the small scale peptide synthesis
facility of the Keck Biotechnology Center at Yale University. Peptides were purified by
reverse phase HPLC, reacted with AlexaFluor-555 C2 maleimide using the protocol of the
supplier (Life Technologies, #A20346), and repurified by HPLC [68]. Host PC12 cells
(“Schweitzer morph A” subclone) and stably transfected derivatives of these cells carrying
genes for the Q25 and Q97 versions of HTT exon1 C-terminally fused to EGFP [47] were
obtained from Erik Schweitzer. Host PC12 cells were transiently transfected to produce GFP
alone by nucleofection using Lonza Kit V per the manufacturer’s optimization protocol for
PC12 cells.
Htt-exon1 expression and cell lysate preparation
PC12 cells were maintained in Dulbecco’s modified media (DMEM) containing 25 nM
HEPES (Cellgro), 5% supplemented calf serum (Hyclone), 5% horse serum (Hyclone), 2 mM
L-glutamine, 0.5 mg/ml G418 (Mediatech and cultured on collagen IV coated plates (Trevi-
gen) at 37°C in 9.5% CO2 ([47] and Erik Schweitzer, personal communication). Cells were
induced with 1 μM ponasterone (Invitrogen) and collected by scraping at different time
points after induction. Cells were washed in warm PBS and pellets were stored at -20°C until
analyzed. Frozen cell pellets were thawed on ice and resuspended in non-denaturing lysis
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.5% v/v Triton X-100) with added protease
inhibitor cocktail (Sigma, P8340-1ML). Samples were cleared by 30 min centrifugation at
2000 g at 4°C and kept on ice until analyzed.
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Fluorescence Correlation Spectroscopy
General. All FCS experiments were performed on a Carl Zeiss LSM-510 METAMP Con-
foCor 3 at the FCS facility at Carnegie Mellon University according to described general proce-
dures [40]. Measurements of Alexa fluor 555 labelled peptides were carried out with a He-Ne
laser (561 nm line) and of EGFP and GFP with an Ar laser (488 nm line). Care was taken to
avoid exceeding the photon counting limit of the detectors. In peptide experiments, this
entailed mixing labelled with unlabeled peptide when concentrations higher than about 0.5 μM
were required. For cell lysate experiments, this entailed carrying out an appropriate dilution of
the clarified lysate in the non-denaturing lysis buffer (above). For live cell experiments, this
entailed keeping post-induction growth times to 6 hrs or less, and/or identifying specific target
cells with appropriate fluorescence intensities.
Peptides. Prior to peptide measurements, cover slides were pretreated with 1 mg/ml BSA
solution for 15 mins then rinsed with water; this pretreatment was required to suppress adsorp-
tive loss of peptides from solution at low peptide concentrations. Alexa-tagged peptides were
disaggregated and their concentrations determined and adjusted [68], and pH 3 stock solutions
were aliquoted into vials, snap frozen in liquid nitrogen, and stored at -80°C prior to use (a
control experiment was performed to ensure that frozen storage over a limited time did not
alter results). For FCS, aliquots of the thawed stock solution were adjusted in volume to attain
the desired concentration in PBS buffer. Samples aliquoted onto the BSA-treated slides were
then incubated for 10 mins (or longer, as indicated) before collecting data.
Live cells. Cells were plated on glass coverslips in Petri dishes, transferred to the FCS facil-
ity, and acclimated in an appropriate incubator for at least one day prior to the experiment.
Cell lysates. Clarified cell lysates were prepared as described above, transferred on ice to
the FCS facility, and diluted into non-denaturing lysis buffer and analyzed.
Analysis. The temporal auto-correlation containing information about concentration and
diffusion time of the fluorescent molecules is given by GðtÞ ¼
X
ini
1
1þtDi
 
1
1þa2tDi
 
, where i
is the number of components and τD is the diffusion time [40]. All FCS data were ﬁt to either
one component or two components depending on the goodness of the ﬁt. The information
about the relative number of particles of each type is calculated from the coefﬁcients ni. For a
single component analysis, the concentrations were calculated directly from the G(0) which is
1/N, N being the number of particles in the focal volume. For two component ﬁts, ni ¼ ci;2i .
The focal volume was calculated using either GFP or Rhodamine B. Knowing the number of
particles and the focal volume, the molar concentration can be calculated. This was converted
to picogram/cell using the calculated molecular weight of the particle of interest, knowledge of
the dilution series applied to the sample, and a standard curve relating cellular protein mass to
cell number (S2 Fig, panel B; see below). All data ﬁtting was done in Origin 7.5.
Brightness analysis, under conditions where the autocorrelation analysis showed only one
species, was carried out by two methods. For the autocorrelation curve method, the number of
particles in the observation volume was calculated from the autocorrelation function and the
relationship G(0) = 1/N. Brightness was calculated by taking the ratio of fluorescent count rate
and N. We compared the brightness of the labelled HTT exon1 solution with that of a solution
of Alexa dye, to generate a ratio equivalent to the number of molecules per particle [40]. For
the photon counting histogram (PCH) method, we analyzed stored raw counts output using
the PCH analysis plugin software for ImageJ software (http://imagej.nih.gov/ij/) provided by
Jay Unruh of the Stowers Institute for Medical Research in Kansas City, MO as described else-
where [45]. The analysis yields a histogram distribution of fluorescence intensity fluctuations,
the average number of molecules in the focal volume, and their molecular brightness.
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Electron microscopy imaging and estimating monomer content of
particles
Aliquots of some reaction mixtures were taken at various time points and analyzed immedi-
ately, without further manipulations, by electron microscopy. EM was carried out as described
[69]. The number of molecules in oligomers, protofibrils, and fibrils imaged in the EM analysis
(Table 2) was approximated by: (a) determining the dimensions of each particle using ImageJ
software (http://imagej.nih.gov/ij/), (b) calculating the internal volumes of each (treating oligo-
mers as spheres and protofibrils/fibrils as cylinders), (c) estimating the mass of the particle
using a value for the density of a folded, globular protein of 1.37 g/cm3 [70],and (d) calculating
the number of molecules of peptide in the particle using its molecular weight and Avogadro’s
number. Approximate particle sizes for each class were then determined by averaging 10–15
example species of each type.
Standard curve of the number of cells versus protein
In order to put analytical HTT exon1 data on a per cell basis over the course of a cell growth
experiment, we developed a correspondence between cell number and total protein. PC12 cells
were grown in normal media until ~70% confluent, trypsinized, pelleted, and counted using a
hemocytomer. Cell counts ranging from 10,000 to 400,000 were aliquoted and lysed using
100 μL of RIPA buffer (Sigma, R0278-50ML). The protein concentration was measured using a
standard Bradford assay. The resulting standard curve (S2 Fig, panel B) was used to determine
the number of cells represented in the lysates analyzed by FCS and by Western blot quantifica-
tion of inclusions.
Estimating cellular HTT exon1 levels by GFPWestern blot
Levels of soluble (monomers, tetramers, and diffusible aggregates) and insoluble (sedimentable
amyloid and inclusions) forms of HTT exon1-Q97 were determined using a GFP epitope in
SDS-PAGEWestern blots. See S1 File.
Caspase 3 activation analysis
Aliquots of clarified lysates (enough volume to deliver 20 μg total protein) of cells harvested at
different times were run on SDS PAGE gels and probed with a rabbit antibody against cleaved
caspase-3 (Asp175, Cell Signalling, #9661S) for WB determination of active phosphorylated
caspase-3. Values were normalized to the level of caspase-3 activation in host PC12 cells grown
for 9 hrs in media supplemented with 5 μM staurosporine (Promega, # A8192).
DNA damage
Nuclear DNA damage was assessed as described [49] and modified [50]. The assay detects sev-
eral types of damage including strand breaks, abasic sites, repair intermediates and others.
Cell respiration analysis
HTT exon1-Q25 or HTT exon1-Q97 PC12 cells per well were seeded onto a 24XF plate and
induced with 1 μM ponasterone at the required time points. The day of the experiment plates
were checked for even confluency and 1 hour before the measurement cells were incubated
with XF assay media (Seahorse Bioscience cat# 102365–100, 1mM sodium pyruvate, 4.5 g/L
Glucose) at 37C without CO2. XF sensor cartridges were hydrated overnight at 37°C, no CO2,
in XF Calibration Buffer cat# 100840–000) and one hour before the measurements the car-
tridge was loaded and calibrated in the XF24 instrument. Basal OCR (oxygen consumption
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rate) was recorded using a Seahorse XF24 Extracellular Flux Analyzer for at least 1 hour. To
normalize the OCR results to the amount of cells present in each well, the media was removed
after the measurements and cells were lysed in RIPA buffer and a BioRad protein assay (cat#
500-0113/4) was carried out to quantify micrograms of protein per well. Methods of assessing
the respiration of permeabilized cells are described in S1 File.
Cytotoxicity
As a measure of cytotoxicity the release of lactate dehydrogenase (LDH) into the growth
medium by cells with damaged membrane was quantified using the CytoTox-ONE™Homoge-
neous Membrane Integrity Assay (Promega) in 96-well plate format.
Statistical analysis
Cellular data were analyzed by GraphPad PRISM. Significance was determined using one-way
ANOVA, followed by post-hoc analysis (Student's t-tests with Bonferroni correction) using
p< 0.05.
Supporting Information
S1 Fig. Time-dependent morphologies by EM of a 2 μM solution of HTTNTQ37P10K2.
(PDF)
S2 Fig. Details of cell measurements.
(PDF)
S1 File. Additional Materials and Methods.
(PDF)
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